ArticleBioelectricity2025
Feline Injection-Site Sarcoma Treated with Surgery, Orthovoltage Radiotherapy, and Electrochemotherapy. A Retrospective Series of 72 Cases.
Article in Bioelectricity, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Feline injection-site sarcoma (FISS) can arise from various agents that induce inflammation in the tissue, such as the injection of vaccines, antibiotics, anti-inflammatories, or even sutures. Patients and Methods: In this retrospective study, 72 cats with FISS grade 1 to 3 located in the spine or costo-abdominal area were included. They were separated into two categories: (A) patients treated with surgery with clean margins alone, surgery plus orthovoltage radiotherapy, and surgery plus electrochemotherapy. And category (B), patients treated with surgery without clean margins, surgery plus orthovoltage radiotherapy, surgery plus electrochemotherapy, and surgery plus orthovoltage radiotherapy and electrochemotherapy. In all cases, surgery with adequate margins was intended. In the cases that the histopathology of the resected tissue showed suboptimal margins, orthovoltage radiotherapy was added after wound healing. In the cases where surgery was performed with insufficient margins, electrochemotherapy was performed in the resection bed during surgery, following the veterinary guidelines for electrochemotherapy. Results and conclusion: Results showed that patients with clean margin resection who underwent surgery alone had no statistically significant improvement in overall survival (OS) or disease-free survival (DFS) when adding orthovoltage radiotherapy or electrochemotherapy. Abstract: Among patients who underwent surgery without clear margins, those treated with surgery alone had a statistically significant shorter DFS and OS. In contrast, patients who received adjuvant orthovoltage radiotherapy, electrochemotherapy, or a combination of both demonstrated improved DFS and OS. However, no statistically significant differences were observed between the various adjuvant treatment modalities. Abstract: In conclusion, when FISS cannot be resected without clean margins, the addition of orthovoltage radiotherapy or electrochemotherapy can provide equal benefits regarding the improvement of DFS and OS times.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.